The argument that a new FDA class of OTC hearing aids will dramatically expand the hearing healthcare market by making hearing aids more affordable is often taken as a “given.” However, research into what economists call “price elasticity”—or how much growth occurs in terms of market penetration when the cost of a product is reduced/increased—tend to suggest otherwise when it comes to hearing aids.